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Summary and perspect ive
Orean transplant:rt ion has evolved from an experirnental procedure in the 1950's and 60's
to the therapy of choice for end-stage organ fai lure. The f irst sol id orsan to outl i row the
experinrental transplantat ion sett ing was the kidney. At that t i rne the succcssful transplant
proÍIrallrs were those in which donor organs from living f:unily mcurbcrs were used for
transplantat ion in their i l l  relat ives ( l iv ing-related transplant combir-rat ion). Dr-re to the
success of these transplantat ions and an incre:rsirts number of patients r 'vi th endstage renal
disease opting for this ncw t l 'eatnlent regimcn a discreplncy benveen denrand and sr"rpply
of kidncy grafts rapidly developed and addit ional donor sources rvcre sought to enl lrge
the donor orgar-r pool. These renrained l imited to l ivins related and a l imited nunrber
of non-heart beating donors unti l  the latc 1960's, when post-mortal organ donation
beclme possible after the inst i tut ion of brain dc.rth. At that t i rrre, technical innovations
made it  possible to maintain an adequate oxyl icn conccntr.rt ion in peripheral t issues by
mechanical venti lat ion in patients without a venti latory drive. This implied a niajor step
in lnesthesiology, while at the s:u1le time in head traumatized heart-belting cadlvers a phase
of temporary stabilization could be achicved. Thr.rs introducins a nerv medical entity, now
refcrred to as brain death. After thorough cl iscussior.r and overconring4 moral,  legal, and
rel igious issues nor,v considering this phase as a ternrinal end point (1), cadaveric donors
became thc rnain source of donor orglns in sol id organ trànsplantat ion A number of
physiological and pathophysioiogical chlnges induccd by brain death have since then been
studied (2-6). However, poter- i t ial  deleterious eÍ lects ofbr:r in death on donor organ viabi l i ty
have not been the subject of any previous str"rdy. This is surprising since a signif icant
dif ference in transplant results can be observcd r 'vhen outcorne of l iv inq related and
unrelatcd (mostly spouses) transplant combinations are conrp:rred to those of cadaveric
trar.rsplant cornbinations (7-9). Outconre after transplantat ion is signif icantly better in the
l iving unrel l ted transplant conbination despite the lact that HLA nutchir.rg is better in the
cadaveric transplant combinatior.r.  These results cannot entirely be explained by shorter
cold ischenria t imes in the elect ive l iving (r.rn) related sett ing. These diÍ ferences h:rve been
consistently observed ar.rd sr-rpport our hypothe sis that the unphysiological state of blain
delth in the cadaveric donor does contr ibute to decreased graft survival.  This effcct could
be caused by imnrune activxt ion of thc potential donor organ. The concept oí immune
activation is based on statelr lents of several authors in the past r 'vho repeatedly have poin-
ted at t l -re fact that the driving forcc behind inrmune responses is the need to recosnize
dar.rger, instead of the historical opiniorr of discrimination bctr,veen self  and non-self (10-
t2). The phase of brain death could very well  be interpreted as a situation of signif iclnt
danger, thus leading to an ade.luatc inunune response. Inunune activ: i ted donor org5ans
would then be transplanted in HLA non-identical recipients subsequently triggering host
allo-responsiveness and increasing the rate ofacute and chronic rejectron.
The aim of this thesis was to analyze whether the phase of brain death in the donor had
deleterious effects, presumably due to immune activation of the potential donor organ,
and thus at least in part- explaining above-mentioned diÍferences in graft survival after
transplantation.
To study this hypothesis first a brain death model in the rat was developed. After vali-
dation of this model and obtaining consistent results a series of subsequent experiments
were carried out.
In the first series of experiments, presented in Chapter r r r the effects of brain death in
hypotensive donors are studied. Hypotension will inevitably occur after onset ofbrain death,
unless adequately treated. In donors with persisting hypotension, referred to as marginal
donors, potential donor organs will suffer more than in normotensive stable donors as
reflected by the increased risk of primary dysfunction once organs retrieved from these
donors are transplanted. Short (1h) and longer term (6h) exposure to a period ofbrain
death was studied and immune cell activation in potential donor liver and kidney tissue
was evaluated. Standard serum parameters were also determined. The data obtained
were compared to those of a normotensive non-brain dead control group. In addition,
hypotensive non-brain dead controls were used to study potential e{fects of hypotension as
such. First, acute and prolonged effects on organ function was shown as demonstrated by
increased concentrations of the liver function marker aspartàte transaminase (113 vs.253
vs.272 in controls, th BD an 6h rats respectively) and kidney function marker creatinine
(43 vs. 87 vs. 178). Furthermore, definite tissue activation was shown by the increased
expression of cell adhesion molecules and a marked influx of leukocytes in kidney (9.1 vs.
1'7 vs. 20 in controls, th BD and 6h BD rats respectively) and l iver t issue (12.3 vs. 13 vs.
27). These effects were not caused by hypotension as such, since no differences between
normotensive non-brain dead controls and hvpotensive non-brain dead controls were
shown in any of the studied parameters.
To determine the effects of brain death without interíerence of hypotension, however,
a normotensive brain death model was used in following studies. In Chapter rv and
v effects of brain death on liver and kidney tissue were separately investigated. In both
series ofexperiments short and longer periods ofbrain death in the presence and absence
of hemodynamic instabiliry were applied. In these studies, rats were randomly allocated
to one of six groups: two sham operated non-brain dead control groups killed th or 6h
after onset of the experiment or four brain dead groups. These rats were killed th or 6h
after onset ofbrain death. During the phase ofbrain death two of these groups, the th and
6h optimal donors received hemodynamic support to maintain normotension. The two
other brain dead groups remained hypotensive. Again, standard serum parameters were
monitored. Immune activation of organs was investigated in more detail. In Chapter rv
the eÍíects of brain death on liver tissue are described. This study showed progressive liver
dysfunction by increased cr-GST le-.'els, most pronounced in hemodynamic unstable brain
dead donors (1h:25 vs. 428 vs. 168 and 6h 18 vs. 919 vs.642 in controls, marginal and
optimal donors, respectivelr. Irrespective of hemodlmamic status, a progressive inflammatory
activation was observed in brain dead rats compared to controls. Increased expression
of cell adhesion molecules facilitated influx of leukocytes into the potential donor liver.
The immune activation resembled a non-specific immune response with the influx of
leukocytes consisting primarily of polymorfo mononuciear cells.
In Chapter v similar effects on kidneys are described showing kidney dysfunction expressed
as increased serum creatinine levels (1h: 59 vs. 87 vs. 60; 6h: 43 vs. 178 vs. 98 in controls,
marginal and optimal brain dead donors, respectively). Both, activation of cell adhesion
molecules and influx of leukocytes in the donor kidney are similar to the obser-vations
in liver tissue. From these studies it was concluded that the phase of brain death in the
donor causes progressive liver and kidney dysfunction, which is enhanced by hemodynamic
instability in the donor. Also, a non-specific immune activation is induced by the onset
of brain death, irrespective of hemodynamic stabilization with influx of primarily poly-
morphomononuclear cells. A similar response is shown in both studied organs indicating
a generalized response instead ofa specific organ oriented reaction.
As part of the inflammatory response, as shown in these liver and kidney biopsies, inflam-
matory mediators and acute phase proteins are upregulated. In addition of being involved
in inflammation, these substances can influence vital processes uch as apoptosis and drug
metabolism capacity of the liver. Especially TNF-c, the key inflammatory mediator, can
activate a potentially detrimental process of apoptosis. On the other hand, binding of
TNF-a on its ligand can also counteract the onset of apoptosis by activation of the NF-
rB regulated survival pathway. In Chapter v r we investigated whether the inÍlammatory
response in the liver of brain dead donors is accompanied by changes in apoptosis and
expression of apoptosis related proteins, in particular those regulated by NF-tcB. Next, we
analyzed which of the two major pathways leading to apoptosis, the cell surface mediated
pathway or the mitochondrial pathway, was activated when induction of apoptosis occur-
red. In this experiment caspase 3 enzyme activity, a downstream effector caspase, was
significantly increased in liver tissue of brain dead rats compared to non-brain dead
control rats (38.1 vs. 17.1 AFU/ptg DNA in 6h brain dead rats vs. non*brain dead controls
respectively). TUNEL staining revealed that the apoptotic cells were primarily hepatocyes.
mRNA levels of all cytokine induced activàtors (Fas, Bid) and inhibitors (A1, BCL-xl,
cIAP2) of both apoptotic pathways were significantly increased in liver tissue of brain dead
donors versus non-brain dead controls. Based on these results we concluded that the phase
ofbrain death induces increased àpoptosis ofhepatocytes despite enhanced expression of
NF-rB dependent anti-apoptotic genes. Apoptosis in hepatocytes is mediated by both
pathways, as has been shown previously under different circumstances. The increased rate
of apoptosis will contribute to a decreased graft viability. Thus, prevention of induction of
apoptosis in the future might indeed improve donor organ viabiliry.
Similar cytokines involved in the process of apoptosis can affect the metabolic liver capacity
contributing to the observed decreased organ viability. Therefore, metabolic capacity was
evaluated using livers of 6h normotensive brain dead rats in Chapter vrr. The livers from
these animals were flushed with cold University of Wisconsin (UW) solution during
explantation. Once cold stored, a liver slice model was used to prepare the liver tissue.
This model enabled us to perform multiple tests on each liver and study the maintenance
of the liver architecture and important cell-cell interactions. Tests were performed after
flush-out and reoxygenation of the liver in the incubation medium. Liver cell integrity was
studied by measuring ATP content and ATP driven urea synthesis. To investigate whether
immune activation induces cytokine production in non-parenchymal cells of the liver (i.e.
KupÍler and endothelial cells), cytokine production (IL-10 and IL-1B) and inducible nitric
oxide synthesis (iNOS) upregulation wàs measured. Effects on metabolic capacity were
studied by determination oíphase 1 and2 metabolism of model compounds. Results show
that the phase ofbrain death, subsequent preservation and re-oxygenation had no effect on
the general cell integrity. Activation of non-parenchymal cells occurred with a temporary
onset of Kupffer cells and a lasting activation of endothelial cells. Upregulation of iNOS
and NOx production was shown indicating cytokine release, although no significant
diÍferences in metabolic liver caoaciw could be observed.
To this point, our studies indicated that the phase of brain death produces less inert
and activated donor organs that will likely provoke an increased immuneresponse after
transplantation resulting eventually in a decreased graft survival. To analyze this a trans-
plant study was perfbrmed that is described in Chapter vrrr. Donor livers used were
derived either from 6h normotensive brain dead rats or non-brain dead control rats. Livers
were flushed with UW solution and immediately transplanted or flushed and cold stored
for 20h in UW solution prior to transplantation in syngeneic recipients. Graft function in
the recipient an animal survival was monitored for 14 days. Serum levels of LDH and AST
LDH and AST were monitored after transplantation. Graít survival of livers derived from
non-brain dead donors both immediately transplanted andlor stored for 20h was 100%.
Survival decreased significantly when livers were procured from brain dead donors even
without any preservation to 75% (6/8). Only 20% (2/1,0) of the animals survived when
livers retrieved from brain dead donors were cold stored for 20h prior to transplantation.
Biopsies of these livers in the latter group showed pericentral necrosis and vacuolization of
hepatocytes. In human transplants these findings are associated with primary dysfunction.
This study showed that brain death induced alterations in the donor liver render it more
sensitive to preservation and ischemia/reperfusion injury than livers used from living
donors which will result in an increased immune-response and decreased graft survival.
Simultaneous to our efforts to better evaluate the effects of brain death on organ viability
the group of Tilney at Harvard University (13) performed kidney allograft experiments.
In their study, they transplanted kid.neys retrieved from brain dead donor rats using a
slow rejecting donor-recipient combination . They were able to show that kidney grafts
harvested from 6h normotensive brain dead donors experienced an accelerated rejection
and had a significantly decreased graft survival compared to those transplanted from non-
brain dead controls. These results confirmed the hypothesis of brain death related injury in
the allogeneic kidney transplant model and are in accordance with our study in the liver
transplant model.
Following our experimental results demonstrating consistent and mounting evidence
of brain death induced alterations to potential donor organs eÍïècts of brain death in
our human donors were studied. We initiated the routine collection of kidney biopsies
prior to organ preservation in the donor, after preservation and after reperfusion in the
kidney graft recipient. Immunohistochemistry and semiquantitative reverse transcriptase-
polymerase chain reaction were performed on the biopsy specimens of 27 cadaveric and
34 living (un)related donor derived biopsies (14). Data from these biopsies confirmed brain
death induced endothelial cell activation by a significant increase in E-selectin expression
and interstitial leukocyte invasion in the cadaveric biopsies. No significant differences
in intercellular adhesion molecule-1 (ICAM-l) and vascular cell adhesion molecule-1
(VCAM-1) between both groups, however, were detected. Furthermore, protective
proteins heme oxygenase (HO)- 1 and heat shock protein (Hsp)70 were significantly
increased after brain death. Evaluation of clinical outcome confirmed a significantly higher
delayed graft function rate and inferior survival rates and creatinine levels in the brain dead
group compared with the living group. The amount of ICAM, VCAM and leukocytes in
the biopsy specimens was shown to be associated with elevated serum creatinine values
one and three years after transplantation and poorer creatinine clearance, which was most
profound in brain dead donors. A positive effect of HO-1 on patient and graft survival
could only be observed in kidneys from living donors, most likely due to the superfluous
amount of damage occurring during brain death.
Koo from Fuggle's group in Oxford (15) also showed endothelial cell activation in kidney
biopsies of cadaveric donors. In their study an immunohistochemical comparison of
postpreservation pretransplant biopsies from cadaveric (N:65) versus living related donor
(N=29) kidneys was performed. High levels of endothelial E-selectin and proximal tubular
expression of HLA-DR antigens were detected. In contrast to our clinical study, they
showed increased levels of ICAM-1, and VCAM-1 in biopsies from cadaveric kidneys,
whereas expression of these markers was markedly reduced in living related kidney
biopsies. The expression of pretransplant ubular antigens in cadaver donor kidneys was
found to be significantly associated with early acute rejection following transplantation.
Both, the work by the Oxford group and our own in human donor organs, indicate that
similar processes are induced by brain death in humans and in animals that will result after
transplantation in increased rates of injury and early acute rejection. Although episodes
of early acute rejection can be effectively treated, grafts once involved in delayed graft
function or an episode of acute rejection show an inferior graft survival (1,6,1,7).
Based on the previously results mentioned, improvement of donor organ viabiliry can be
achieved by prevention of upregulation of inflammatory mediators during brain death.
Recently, Pratschke et al. performed the first intervention study with promising results
(18). In a kidney transplant study four groups of F344 rats were used as organ donors and
Lewis rats as recipients. In this weak strain combination the acute rejection process occurs
at an attenuated tempo, emphasizing any donor-associated changes. In three of the four
donor groups brain death was induced. One group served as non-brain dead control. After
brain death induction rats were either not treated, injected with glucocorticoids or injected
with soluble P-selectin glycoprotein ligands GPSGL). Steroids were administered to reduce
the release of inflammatory cytokines, sPSGL was given to prevent leukocyte adhesion
to the inflamed vascular endothelium of the graft. Infiltration of cells occurred in relative
small numbers before transplantation in the kidneys of living donor controls and treated
brain dead donor groups. Recipients of kidney allografts from untreated brain dead donors
experienced an accelerated rate of acute rejection and died of renal failure significantly
earlier than controls. Recipients of treated kidneys showed survival times comparable
to living donor controls and significantly better than the untreated allografts. This study
suggests that counteracting the eÍIects of brain death is feasible in the rat model. The best
treatment options and time to start treatment will be subject to future experimentation.
To improve treatment modalities a better understanding of the cause leading to immune
activation is crucial. Therefore, we performed studies that analyse eÍiècts of brain death in
more detail using the DNA microarray technique (19). Both human and rat tissue biopsies
are tested on expression of multiple genes. In the first study involving kidney tissue of 6h
brain dead rats most genes were categorized in potential interesting diÍêrent functional
groups: Metabolism,/Transport, Inflammation/Coagulation, Cell Division/Fibrosis and
Defence/Repair. Also, genes encoding transcription factors and proteins involved in
signal transduction were identified. In this study, we could show that brain death leads via
activation oftranscription factors and signal transduction cascades to diÍferential expression
of different 'effector' genes. Not only deleterious processes as inflammation and fibrosis
occurred in rat brain dead donor kidneys but genes involved in protection and early-repair
processes are activated as well. A similar study is currently being performed using human
kidney biopsies taken before and after transplantation.
In conclusion, we have shown that brain death should no longer be considered as a static
and given condition, but as a dynamic process that significantly influences the viability
of peripheral potential donor organs. Duration of brain death should be kept as short as
possibie and hemodynamic instability should be counteracted. The first crude treatment
regimen in the brain dead donor decreases the alloimmune response after transplantation
and improves graft survival in animal models.
The sum of the collected data, on the effects of brain death and unphysiological stress
on the donor organ viability, up to now shows great potential for future research. A first
impression has been formed concerning mechanisms playing a crucial role in the decreased
donor organ quality. In the years to come, the possibilities of targeted cytoprotective
interventions in brain dead donors must be explored to improve donor organ viability
or maintain it at the current level while expanding the donor criteria. In this process the
contribution of this thesis is only the tip of the iceberg.
